Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0363 | ||||
| Gene Name | SLC44A1 | ||||
| Protein Name | Choline transporter-like protein 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
| Synonyms | CD92; CDw92; CHTL1; CTL1; SLC44A1; Solute carrier family 44 member 1 | ||||
| DT Family | Choline Transporter-Like (CTl) Family ; | ||||
| Tissue Specificity | Expressed in various cells of thehematopoietic system. | ||||
| Function | This transporter is for choline transport and may be involved in membrane synthesis and myelin production. | ||||
| Endogenous Substrate(s) | Choline | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
(ε) Exogenous Modulation of This DT |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(α) Genetic Polymorphisms of This DT |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Choline
|
Phase 3 | Drug Info | Elderly bronchial asthma | CA23 | [1] |
|
Drug-DT Affinity Assessed by Cell Line |
|||||
|
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Cell Line | Affinity | Ref |
| Choline | Phase 3 | Drug Info | A549 and rat ATII cells | Km = 15 microM | [1] |
| References | |||||
| 1 | Decreased biosynthesis of lung surfactant constituent phosphatidylcholine due to inhibition of choline transporter by gefitinib in lung alveolar cells. Pharm Res. 2008 Feb;25(2):417-27. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.